No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Note

On Friday, March 5th (posted on SEDAR March 8th as an Exempt Distribution) there was a transaction for a Promissory Note worth $1,900,200 CAD with a Chinese party. The transaction was made in USD so was probably for $1.5 million USD.

4
Mar 09, 2021 08:47PM
3
Mar 10, 2021 07:12AM
1
Mar 10, 2021 07:19AM
1
Mar 10, 2021 01:17PM
3
Mar 10, 2021 04:16PM
Share
New Message
Please login to post a reply